FDA OKs First Gene Therapy Implant for a Rare Eye Disease

The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss.
WebMD Health News

source https://www.medscape.com/s/viewarticle/fda-oks-first-gene-therapy-implant-rare-eye-disease-2025a10005r0?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?